https://www.selleckchem.com/pr....oducts/carfilzomib-p
Although the cumulative survival of the albumin plus mixed plasma group was higher than the other group starting from day 23 after treatment, we did not observe significant difference (P = .5. No significant increase in the risk for hemorrhage was observed in either group. CONCLUSIONS The therapeutic efficacy of albumin and mixed plasma (211) is not inferior to that of albumin and FFP (11), and it can be used in treating TTP. © 2020 Wiley Periodicals, Inc.INTRODUCTION Constant evaluation of the outcomes of laparoscopic intr
Like
Comment
Share